Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.
复制标题

DOI:
10.1080/21678421.2016.1267768
复制
发表时间:
2017-05
影响因子:
2.8
通讯作者:
Turner MR
Turner MR
中科院分区:
医学4区
文献类型:
--
作者:
Strong MJ;Abrahams S;Goldstein LH;Woolley S;Mclaughlin P;Snowden J;Mioshi E;Roberts-South A;Benatar M;HortobáGyi T;Rosenfeld J;Silani V;Ince PG;Turner MR

文献摘要

参考文献

被引文献

相似文献

本文基于 2015 年 6 月在加拿大伦敦举行的额颞叶痴呆 (FTD) 和 ALS 国际研究研讨会,提出了肌萎缩侧索硬化症 (ALS) 额颞叶功能障碍诊断的修订共识标准。自 Strong 标准发布以来,对 ALS 患者神经心理学特征的理解取得了相当大的进展。神经心理学发现的广度和深度不仅比以前认识的更广泛——包括社会认知和语言缺陷——而且还可能出现混合缺陷。现在的证据表明,ALS 患者的神经心理缺陷具有极大的异质性,影响了超过 50% 的 ALS 患者。当存在时,这些缺陷会对患者的生存产生显着的不利影响。正是认识到这种与神经影像学、遗传学和神经病理学进展相关的临床异质性,导致了当前的重新概念化,即 ALS 的神经心理缺陷属于一个范围。这些修订后的共识标准在 2009 年的基础上进行了扩展,并包含了 ALS 额颞叶谱系障碍 (ALS-FTSD) 的概念。
This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop on frontotemporal dementia (FTD) and ALS held in London, Canada in June 2015. Since the publication of the Strong criteria, there have been considerable advances in the understanding of the neuropsychological profile of patients with ALS. Not only is the breadth and depth of neuropsychological findings broader than previously recognised – – including deficits in social cognition and language – but mixed deficits may also occur. Evidence now shows that the neuropsychological deficits in ALS are extremely heterogeneous, affecting over 50% of persons with ALS. When present, these deficits significantly and adversely impact patient survival. It is the recognition of this clinical heterogeneity in association with neuroimaging, genetic and neuropathological advances that has led to the current re-conceptualisation that neuropsychological deficits in ALS fall along a spectrum. These revised consensus criteria expand upon those of 2009 and embrace the concept of the frontotemporal spectrum disorder of ALS (ALS-FTSD).
DOI: 10.1016/j.neurobiolaging.2016.03.028
发表时间: 2016-07
影响因子: 4.2
作者:
Borghero G;Pugliatti M;Marrosu F;Marrosu MG;Murru MR;Floris G;Cannas A;Occhineri P;Cau TB;Loi D;Ticca A;Traccis S;Manera U;Canosa A;Moglia C;Calvo A;Barberis M;Brunetti M;Gibbs JR;Renton AE;Errichiello E;Zoledziewska M;Mulas A;Qian Y;Din J;Pliner HA;Traynor BJ;Chiò A;ITALSGEN and SARDINALS Consortia
通讯作者: ITALSGEN and SARDINALS Consortia
DOI: 10.1212/01.wnl.0000156519.41681.27
发表时间: 2005-04-12
期刊: NEUROLOGY
影响因子: 9.9
作者:
Abrahams, S;Leigh, PN;Goldstein, LH
通讯作者: Goldstein, LH
DOI: 10.3109/21678421.2014.974617
发表时间: 2015-03
影响因子: 2.8
作者:
Ash S;Olm C;McMillan CT;Boller A;Irwin DJ;McCluskey L;Elman L;Grossman M
通讯作者: Grossman M
DOI: 10.1007/s00401-011-0911-2
发表时间: 2011-12-01
影响因子: 12.7
作者:
Al-Sarraj, Safa;King, Andrew;Shaw, Christopher E.
通讯作者: Shaw, Christopher E.
DOI: 10.1186/s40478-016-0301-z
发表时间: 2016-03-31
影响因子: 7.1
作者:
Behrouzi R;Liu X;Wu D;Robinson AC;Tanaguchi-Watanabe S;Rollinson S;Shi J;Tian J;Hamdalla HH;Ealing J;Richardson A;Jones M;Pickering-Brown S;Davidson YS;Strong MJ;Hasegawa M;Snowden JS;Mann DM
通讯作者: Mann DM